Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-240-0 | CAS number: 79-97-0
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Review of toxicokinetic data as required by Annex VIII of REACH. The available test data do not permit extensive conclusions concerning absorption, metabolism or excretion to be conclusively drawn. Acute toxicity (via the oral route) and repeated oral administration results, no mortality was observed although treatment related systemic effects were reported.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
Additional information
Repeated oral administration of the test substance (in an OECD 421 study) to rats provided paternal NOAEL of 250 mg/kg/day. The clinical signs evident at the top dose indicated that some absorption and distribution of the test substance can be expected. At 62.5 and 250 mg/kg/day, no adverse effects were noted and it is possible that bioelimination through normal metabolic and excretory pathways allows some removal of the test substance, with the potential for these pathways to be overwhelmed at the top dose.
The substance was determined to be a skin sensitiser based on the results of 3 in chemico/in vitro skin sensitisation assays (weight-of-evidence assessment), indicating that the test substance potentially has the ability to pass through the dermal layers of the skin or produce systemic effects; it was noted that loss of fur was evident in the oral reproductive screening test.
Based on the relatively low Log Kow values (<4.5) and low aqueous solubility of the test substance, bioaccumulation of the test substance is expected to be low.
No in vivo mutagenicity/clastogenicity data are available. It was observed in an in vitro chromosome aberration assay that the test substance was clastogenic to human lymphocytes with the possible indication that test substance is absorbed and not excreted without any toxicological effects.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
